1. miR-330-5p inhibits NLRP3 inflammasome-mediated myocardial ischaemia–reperfusion injury by targeting TIM3

   • Wei Zuo
   • Ran Tian
   • Zhenyu Liu

   Original Article 02 November 2020 Pages: 691 - 705

   

2. Toward Better Reproducibility in Experimental Research on New Agents for Pulmonary Hypertension. An Analysis of Data from Four Hundred Animal Studies

   • Magdalena Jasińska-Stroschein

   Original Article Open access 09 December 2020 Pages: 707 - 718

   

3. BK_Ca Channel Activation Attenuates the Pathophysiological Progression of Monocrotaline-Induced Pulmonary Arterial Hypertension in Wistar Rats

   • Ana Paula Ferraz
   • Fernando A. C. Seara
   • Jose Hamilton M. Nascimento

   Orignal Article 27 November 2020 Pages: 719 - 732

   

4. Chronic Naltrexone Therapy Is Associated with Improved Cardiac Function in Volume Overloaded Rats

   • Lukas Dehe
   • Mohammed Shaqura
   • Sascha Treskatsch

   Routine Article Open access 23 January 2021 Pages: 733 - 743

   

5. The Redox Modulating Sonlicromanol Active Metabolite KH176m and the Antioxidant MPG Protect Against Short-Duration Cardiac Ischemia-Reperfusion Injury

   • Yang Xiao
   • Karen Yim
   • Coert J. Zuurbier

   Original Article Open access 29 April 2021 Pages: 745 - 758

   

6. Effects of Angiotensin Receptor-Neprilysin Inhibitor in Arrhythmogenicity Following Left Atrial Appendage Closure in an Animal Model

   • Wen-Han Cheng
   • Isaiah C. Lugtu
   • Li-Wei Lo

   Original Article 05 April 2021 Pages: 759 - 768

   

7. Ang II Promotes SUMO2/3 Modification of RhoGDI1 Through Aos1 and Uba2 Subunits, and then Regulates RhoGDI1 Stability and Cell Proliferation

   • Yan Qi
   • Haijing Guan
   • Wenjuan Yao

   Short Communication 23 April 2021 Pages: 769 - 773

   

8. Cost-Effectiveness of Evolocumab Therapy for Myocardial Infarction: The Chinese Healthcare Perspective

   • Zhe Liang
   • Qi Chen
   • Quanming Zhao

   Original Article 22 October 2020 Pages: 775 - 785

   

9. Assessment of Low LDL Cholesterol in Patients Treated by PCSK9 Inhibition: Comparison of Martin/Hopkins and Friedewald Estimations

   • Aya Egbaria
   • Walid Saliba
   • Barak Zafrir

   Short Communication 23 November 2020 Pages: 787 - 792

   

10. Association Between Omega-3 Fatty Acid Treatment and Atrial Fibrillation in Cardiovascular Outcome Trials: A Systematic Review and Meta-Analysis

    • Xiaoming Jia
    • Feng Gao
    • Christie M. Ballantyne

    Original Article 31 May 2021 Pages: 793 - 800

    

11. Medical Treatment in Coronary Patients: Is there Still a Gender Gap? Results from European Society of Cardiology EUROASPIRE V Registry

    • Pieter Vynckier
    • Giulia Ferrannini
    • On behalf of the EUROASPIRE V Investigators group

    Original Article 17 October 2020 Pages: 801 - 808

    

12. Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes

    • Marco Witkowski
    • Julian Friebel
    • Ursula Rauch

    Short Communication Open access 17 September 2020 Pages: 809 - 813

    

13. CD38: A Potential Therapeutic Target in Cardiovascular Disease

    • Wanyun Zuo
    • Na Liu
    • Qiming Liu

    Review Article 29 May 2020 Pages: 815 - 828

    

14. Cost-Effectiveness of Endovascular Versus Open Repair of Abdominal Aortic Aneurysm: A Systematic Review

    • Shahin Nargesi
    • Ali Abutorabi
    • Javad Salimi

    Review Article 09 February 2021 Pages: 829 - 839

    

15. Bempedoic Acid in the Treatment of Patients with Dyslipidemias and Statin Intolerance

    • Andrey V. Susekov
    • Ludmila A. Korol
    • Gerald F. Watts

    Review Article 27 January 2021 Pages: 841 - 852

    

16. Role of Bempedoic Acid in Clinical Practice

    • Christie M. Ballantyne
    • Harold Bays
    • Joseph J. Saseen

    Review Article Open access 05 April 2021 Pages: 853 - 864

    

17. Correction to: Role of Bempedoic Acid in Clinical Practice

    • Christie M. Ballantyne
    • Harold Bays
    • Joseph J. Saseen

    Correction Open access 19 April 2021 Pages: 865 - 865

18. Eliminating Gender Disparities in Coronary Heart Disease Treatment: Are We There Yet?

    • Radmila Lyubarova
    • Gurleen Kaur
    • Mandeep S. Sidhu

    Invited Editorial 18 November 2020 Pages: 867 - 869

19. Aspirin for Primary Cardiovascular Prevention in Patients with Family History of Cardiovascular Disease: Meta-analysis

    • Miguel M. Antunes
    • Mariana Alves
    • Daniel Caldeira

    Letter to the Editor 16 October 2020 Pages: 871 - 873

    

20. Prediction of the Individual Risk of Bleeding in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

    • Patrick Sulzgruber
    • Felix Hofer
    • Alexander Niessner

    Letter to the Editor 04 March 2021 Pages: 875 - 876